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ABSTRACT 
 
Introduction: The process of laryngoscopy and endotracheal intubation are noxious stimuli and is associated with 
intense sympathetic activity which may precipitate intra-operative complications. Aim:To study the efficacy of 
intravenous dexmedetomidine in attenuation of hemodynamic response to laryngoscopy and endotracheal 
intubation. Materials and Methods: This was a prospective study conducted in a group of hundred patients. The 
study population was divided randomly into two groups.Group C – Control group (n=50) – received 10 ml of 
normal saline intravenously over 10 minutes, 10 minutes before induction and Group D – (n=50) – received 
Dexmedetomidine in the dose of 0.6 µg/kg body weight diluted in 10 ml of  normal saline. Results: There was 
marked decrease in HR 10 minutes after Dexmedetomidine administration. HR, SBP, DBP and MAP markedly 
increased at 1 minute following laryngoscopy and intubation in the control group where as in Dexmedetomidine 
group there was a fall in HR, SBP, DBP and MAP at all times which was statistically significant. There was reduced 
thiopentone requirement and no increased sedation scoring in patients belonging to Dexmedetomidine group 
compared to control group. There were minimal side effects noted in the Dexmedetomidine group which were 
managed easily.  Conclusion: Dexmedetomidine at a dose of 0.6µ/kg body weight given 10 minutes before 
induction significantly attenuated the hemodynamic response to laryngoscopy and tracheal intubation and there was 
reduction in dose requirement of thiopentone sodium without significant side effects 
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Introduction 
 
The process of laryngoscopy and endotracheal 
intubation are noxious stimuli and therefore constitute 
a period of extreme hemodynamic stress and is 
associated with intense sympathetic activity marked by 
tachycardia and hypertension[1]. These changes are 
usually transient and insignificant in healthy 
individuals but may be hazardous to those with 
cardiovascular or cerebrovascular diseases[2].Pressor 
response may result in intra-operative myocardial 
infarction, acute left ventricular failure, intracranial 
bleed[3] and dysrhythmias[4].Intravenous anesthetic  
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induction agents do not adequately or predictably 
suppress the circulatory responses induced by 
endotracheal intubation[5]. So, prior to initiating 
laryngoscopy, additional pharmacological measures are 
taken. Various studies have found that 
Dexmedetomidine can decrease the hemodynamic 
response to laryngoscopy and intubation[6].  The 
present study is aimed at attenuation of hemodynamic 
response to laryngoscopy and endotracheal intubation 
with Dexmedetomidine at 0.6µg/kg body weight.We  
study the efficacy of intravenous dexmedetomidine in 
attenuation of hemodynamic response to laryngoscopy 
and endotracheal intubation. 
 
Materials and methods 
 
This study was a Prospective Randomized Double 
Blind Controlled Clinical study conducted at Prathima 
Institute of Medical Sciences, Karimnagar over a 
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period of one year. The study group consisted of 
hundred patients. Informed consent was taken from all 
the patients. 
Inclusion criteria: Adult patients aged between 18 and 
50 years of both sex, posted for elective surgeries 
under general anesthesia and belonging to ASA 
physical status I and II, and Mallampatti grade I and II. 
Exclusion criteria:Patients with hypertension, cardiac, 
coronary, renal, hepatic, cerebral diseases, peripheral 
vascular diseases and endocrinal diseases, heart rate 
less than 60 bpm, systolic blood pressure less than 100 
mm of Hg, presence of heart block, difficult airway and 
obese patients (BMI>30). 
Mode of selection:The study population was randomly 
divided into two groups with 50 patients in each group 
using sealed envelopes containing the name of the 
group and patient was asked to pick up the envelope. 
The envelope was opened by senior anesthesiologist 
who was assigned to prepare the solutions and not 
involved with the study. 
Group C - Control group(n=50): received 10 ml of 
normal saline intravenously over 10 min, 10 minutes 
prior to induction using syringe pump. 
Group D – Dexmedetomidine (n=50): received 
injection Dexmedetomidine 0.6µg/kg body weight 
diluted to 10 ml normal saline intravenously over 10 
min, 10 minutes prior to induction using syringe pump. 
Preoperative period: Investigations done were: 
complete blood picture, complete urine examination, 
electrocardiogram, X-ray chest, blood sugar, blood 
urea, serum creatinine. Pre-anesthetic evaluation was 
done in the evening before the day of surgery.   
Intra operative period: The patients were connected 
to multiparameter monitor. The baseline systolic, 
diastolic blood pressure, mean arterial pressure and 
heart rate were recorded. The cardiac rate and rhythm 
were also monitored from a continuous visual display 
of electrocardiogram from lead II.  
The premedication, induction agent and muscle 
relaxant were standardised for both the groups. 
After recording the baseline reading, study group – 
group D patients were given Dexmedetomidine 
0.6µg/kg body weight diluted in 10 ml normal saline 
intravenously over 10 min, 10 min before induction 
using syringe pump and in control group only normal 
saline 10 ml was given. The study drug was prepared 
by the senior anesthesiologist who was not involved 
with the study and observer as well as patient were 
blinded for the study. All the patients were 
premedicated with injection Glycopyrrolate 
0.008mg/kg body weight, injection Midazolam 
0.02mg/kg body weight and injection Fentanyl 1µ/kg 
body weight IV after test drug administration. Ninety 
seconds before intubation all patients received IV 
Lignocaine 1.5mg/kg body weight. Patient was induced 
with injection Thiopentone sodium 5 mg/ kg body 
weight, as a 2.5% solution till loss of eye lash reflex 
occurred and dose of Thiopentone sodium required for 
loss of eye lash reflex recorded. Endotracheal 
intubation was facilitated with injection Vecuronium 
0.1mg/kg.Anesthesia was maintained appropriately. No 
surgical or any other stimulus was applied during 10 
minutes of study period and Vecuronium was the only 
additional drug given during this 10 minutes period. At 
the end of the procedure patients were reversed with 
injection Neostigmine 0.05 mg/kg body weight and 
injection Glycopyrrolate 0.01 mg/ kg body weight. 
Sedation at the end of the surgery was assessed using 
Ramsay sedation score. 
Monitoring: The following cardiovascular parameters 
were recorded in all patients: Heart rate, Systolic blood 
pressure, Diastolic blood pressure, Mean arterial 
pressure [MAP] in mm of Hg in the following time 
interval – Basal before giving study drug, then 2 
minutes, 5 minutes, 8 minutes after giving study drug, 
before induction, after induction, 1 minute, 3 minutes, 
5 minutes, and 10 minutes after laryngoscopy and 
intubation. 
Side effects: Hypotension was defined as SBP ≤ 20% 
of baseline value.[7] Tachycardia as HR > 25% of 
baseline value.[8] Bradycardia as HR < 60 beats/ 
minute.[5] Dysrhythmia as any ventricular or supra 
ventricular beat or any rhythm other than sinus 
rhythm.[8] The side effects of the study drug like 
hypotension, bradycardia and sedation were noted. 
Sedation scoring was as per Ramsay sedation scale.[9]  
 
Results 
 
The minimum age in groups C and D were 20 and 18 
years respectively. The maximum age in both groups 
was 55 years. The mean age in group C and D were 
36.8±9.7 and 36.42± 9.36 respectively. There was no 
significant difference in the age of patients between the 
Group C and Group D. Both groups were similar with 
respect to age distribution (p=0.835).  
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Table 1: Demographic distribution in study 
 
Age (years) Group C  (Control)  Group(Dexmedetomidine)  
 No. of patients Percentage No. of patients Percentage 
18-28 12 24 13 26 
29-38 13 26 12 24 
39-48 15 30 20 40 
49-55 10 20 05 10 
Total 50  50  
Mean age in years±SD 36.8±9.7  36.42± 9.36  
p-value 0.835 (NS)    
Gender distribution 
Male 27 54 22 49 
Female 23 56 28 56 
Total 50 100 50 100 
40-44 0 0 3 6 
45-49 10 20 8 16 
50-54 10 20 14 28 
55-59 9 18 13 26 
60-64 18 36 6 12 
65-69 2 4 4 8 
70+ 1 2 2 4 
Total 50 100 50 100 
Mean body weight in kg± SD 56.12±6.15  55.34±7.56  
Minimum body weight in kg 45  43  
Maximum body weight  in kg 70  73  
p-value 0.189 (NS)    
 
Gender distribution: In group C there were 27 (54%) 
males and 23 (56%) females. In group D there were 22 
(49%) males and 28 (56%) female patients. 
Statistically there was no significant change in the 
gender in both the groups. 
Body weight: The minimum body weight in groups C 
and D were 45 kg and 43 kg respectively. The 
maximum body weight in groups C and D were 70 kg 
and 73 kg respectively. The mean body weight in 
Group C was 56.12 ± 6.15 and in Group D it was 55.34 
± 7.56. There was no significant difference in the body 
weight of patients between the Group C and Group D 
(p=0.189). 
 
 
Fig 1: Type of surgeries done in study 
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Type of surgery: For group C and group D 
respectively, there were 26 cases and 18 cases who 
underwent general surgeries, 5 cases and 11 cases who 
underwent gynaecological surgeries, 69 cases and 7 
cases who underwent orthopaedic surgeries and 10 
cases and 14 cases who underwent ENT surgeries.  
The type of surgeries comprised of excision of lipoma, 
fibroadenoma, cervical rib, cervical lymph node, 
thyroglossal cyst excision, exploration of sinus tract, 
etc.  
 
 
 
 
Fig 2: Mean duration of surgery 
 
In control group the mean duration of surgery was 90.08±10.7 minutes and in Dexmedetomidine group 88.92±11.8 
minutes which was statistically not significant (p=0.078).(Fig 2) 
 
 
(p<0.01) – Highly significant (HS); (p<0.05) – Significant (S); 
(p>0.05) – Not significant (NS); AD-After drug administration; AI- After intubation 
 
Fig 3: Intergroup comparison of mean heart rate (bpm) changes in response to laryngoscopy and intubation 
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The basal heart rate was comparable in both groups (p=1.000). There was a significant fall in HR in group D at 2, 5 
and 8 minutes of drug administration and before and after induction. The mean HR increase observed at 1, 3, 5 and 
10 minutes after intubation in group C was statistically highly significant compared to mean HR in group D 
(p=0.000).(Fig 3) 
 
 
 
 
(p<0.01) – Highly significant (HS); (p<0.05) – Significant (S); 
(p>0.05) – Not significant (NS); AD-After drug administration; AI-After intubation 
 
Fig 4: Intergroup comparison of mean systolic blood pressure (SBP in mmHg) changes in response to 
laryngoscopy and intubation 
 
The mean SBP were comparable in both groups (p=0.734). The mean SBP values at 5 and 8 minutes of drug 
administration, before and after induction were significantly low in group D (p=0.000) compared to group C. The 
increase in SBP in group C at 1,3, 5 and 10 minutes after intubation was statistically highly significant (p=0.000) 
compared to group D.(Fig 4) 
 
 
           (p<0.01) – Highly significant (HS); (p<0.05) – Significant (S); 
           (p>0.05) – Not significant (NS); AD-After drug administration; AI-After intubation 
 
Fig 5: Intergroup comparison of mean diastolic blood pressure (DBP in mmHg) changes in response to 
laryngoscopy and intubation 
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The mean basal DBP are comparable in both groups (p=0.223). The mean DBP values at 5 and 8 minutes of drug 
administration, before and after induction were significantly low (p=0.000) compared to group C. The increase in 
DBP in group C at 1, 3, 5 and 10 minutes after intubation was statistically highly significant (p=0.000) compared to 
group D.(Fig 5) 
 
 
 
 
                    (p<0.01) – Highly significant (HS); (p<0.05) – Significant (S); 
                    (p>0.05) – Not significant (NS); AD-After drug administration; AI-After intubation 
 
Fig 6: Intergroup comparison of mean arterial pressure (MAP in mmHg) changes in response to 
laryngoscopy and intubation 
 
The mean basal MAP are comparable in both groups (p=1.000). There was a significant difference in MAP values at 
5th min, 8th min after drug administration and before and after induction which was statistically highly significant 
(p=0.000). The increase in MAP in group C was statistically highly significant at 1 min and 3, 5 and 10 minutes 
after intubation (p=0.000) compared to group D(Fig 6) 
 
Table 3: Showing the dose of thiopentone required and sedation score 
 
Mean Dose of thiopentone required for induction(mg) 
Group C 278±34.49 
Group D 170.5±30.17 
p-value 0.000 (HS) 
Sedation score 
Group C 2.62±0.49 
Group D 2.52±0.43 
p-value 0.087 (NS) 
 
 (p<0.01) – Highly significant (HS); (p<0.05) – Significant (S)(p>0.05) – Not significant (NS)  
The mean dose of thiopentone sodium required for loss of eye lash reflex in group C and group D were 278±34.49 
and 170.5±30.17 respectively.Statistical evaluation between the groups showed a statistically highly significant 
reduction in dose of thiopentone sodium required for induction (p=0.000). 
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In group C sedation score was 2.62±0.49 and in group D the score was 2.52±0.43. Statistical evaluation showed no 
difference in the sedation score between the two groups. 
 
 
 
 
Fig 7: Side effects between control and Dexmedetomidine group 
 
In group C, none of the patients had side effects like bradycardia and hypotension. In group D, 4 patients had 
bradycardia, 3 had hypotension and one patient had both bradycardia and hypotension. The p –value was 0.034 
which is statistically significant. But all the cases were easily manageable.(Fig 7) 
 
Discussion 
 
Most of the general anesthesia procedures in the 
modern anesthetic practice are carried out with 
endotracheal intubation. Laryngoscopy and tracheal 
intubation are considered as the most critical events 
during administration of general anesthesia as they 
provoke transient but marked sympathoadrenal 
response manifesting as hypertension and 
tachycardia.[10]These responses are transitory, 
variable and may not be significant in otherwise 
normal individuals. But in patients with cardiovascular 
compromise like hypertension, ischemic heart disease, 
cerebrovascular disease and in patients with 
intracranial aneurysms, even these transient changes in 
hemodynamics can result in potentially harmful effects 
like left ventricular failure, pulmonary edema, 
myocardial ischemia,and cerebral hemorrhage.[3] 
Many methods like use of inhalational anesthetic 
agents, lidocaine,[11] opioids,[12] and β-blockers[13] 
have been tried by various authors for blunting 
hemodynamic responses to laryngoscopy and 
intubation. But all such manoeuvres have their own 
limitations. Beta blockers blunt the heart rate response 
better than blood pressure response.[13] Hence, a drug 
which can blunt both the heart rate response and blood 
pressure response of laryngoscopy and intubation, 
without having any adverse effects like respiratory 
depression and post-operative nausea and vomiting 
(PONV), was required for the purpose. 
Dexmedetomidine is one such drug.[14]  
Dexmedetomidine has been found by various 
authors[6, 7, 15, 16, 17, 18] to blunt the hemodynamic 
response for laryngoscopy and intubation. 
Dexmedetomidine has been recently introduced in 
India (in 2009) and not many studies have been done 
using Dexmedetomidine for suppression of intubation 
response. Hence, it was taken up as a study subject. 
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Both the groups were comparable and there was no 
statistically significant difference with regards to the 
mean age, weight, sex and duration of surgery. 
Dose of Dexmedetomidine employed and 
administration 
Various authors have employed intravenous 
Dexmedetomidine for blunting hemodynamic response 
to laryngoscopy and intubation in different doses. 
Kallio et al [19] showed that the maximum inhibition 
of sympathetic nervous system activity occurred at 50 
and 75µg of Dexmedetomidine dose. 
Kunisawa et al [17] used 1µg/kg body weight of 
Dexmedetomidine with fentanyl and found that, though 
there was a decrease in HR, the decrease in blood 
pressure was suppressed. 
Esra et al [9] used 0.5 and 1µg/kg body weight of 
Dexmedetomidine for suppression of intubation 
response and did not find any significant change 
regarding HR in both doses. 
Aho et al [7] observed that a dose of 0.6µg/kg body 
weight was more effective in blunting hemodynamic 
response to laryngoscopy and intubation than 0.3µg/kg 
body weight dose. 
Scheinin et al, [14] Jakola et al [6]  and Mowafi et al 
[15] showed that bolus dose of 0.6µg/kg body weight 
Dexmedetomidine given 10 min before induction 
effectively attenuated the sympathoadrenal responses 
associated with laryngoscopy and tracheal intubation.In 
keeping with observation of above authors, we chose 
0.6µg/kg body weight dose of dexmedetomidine for 
our study. 
Method of administration 
Rapid bolus dose of Dexmedetomidine, results in 
initial transient increase in blood pressure and reflex 
decrease in HR which is due to peripheral α-2 
adrenoceptors stimulation of vascular smooth muscle 
and can be attenuated by a slow infusion over 10 
minutes. The administration of drug over 10 minutes is 
similar to the studies by Mowafi et al [15] Basar et al 
[16] and Kunisawa et al [17]  
 The administration of Dexmedetomidine as 10 ml in 
the present study is similar to the administration by 
Scheinin et al [14]  and Basar et al. [16]  
Timing of administration of Dexmedetomidine 
The distribution half-life of intravenous 
Dexmedetomidine is approximately 6 minutes. 
Various authors, Aho et al [7] Scheinin et al [14] 
Jakola et al [6] Mowafi et al [15]  and Keniya et al [20]  
have employed Dexmedetomidine, 10 minutes before 
induction and hence, we too adopted the same method. 
Comparative analysis of hemodynamic data 
between the Dexmedetomidine and control groups 
at various intervals 
I. Changes in heart rate after Dexmedetomidine and 
saline administration 
Various authors have found[6,7, 17, 18] that 
Dexmedetomidine decreased the HR at various 
intervals of 2,5,8 and 10 minutes. Our study also found 
similar change in HR which is statistically highly 
significant.  
In the control group, initially there was not much 
variation in HR after the administration of saline in the 
first 10 minutes whereas, in Dexmedetomidine group 
there was a continuous decrease in HR at 2, 5, 8 and 10 
minutes which was statistically highly significant 
After induction: values also showed increased heart 
rate in group C and reduced heart rate in group D. Our 
present study compares well with the findings of 
Kunisawa et al. [17]  
After laryngoscopy and intubation 
At 1st min- In the present study, following 
laryngoscopy and intubation at 1 minute, the mean HR 
increased in the control group and decreased in 
Dexmedetomidine group which was statistically highly 
significant (p=0.000). Various authors[15,16] have 
found similar response to intravenous 
Dexmedetomidine at 1 min after intubation. 
At 3rd min- The increase in mean HR at 3rd minute in 
control group was 29.04 bpm whereas in 
Dexmedetomidine group the HR decreased by 4.98 
bpm which is statistically highly significant (p=0.000).  
At 5th min- The increase in mean heart rate in control 
group sustained even at 5th minute, whereas, in 
Dexmedetomidine group there was further decrease in 
HR which was statistically highly significant(p=0.000). 
Similar findings were reported by Jakola et al [6] and 
Scheinin et al. [14]  
At 10th minute- In our study even at 10th minute, 
there was increase in HR in control group compared to 
basal level and in Dexmedetomidine group, the HR 
remained low by 10.46 bpm which was statistically 
highly significant (p=0.000).We could not compare out 
results with other authors as they have not studied the 
hemodynamic parameters at 10th minute. 
Basar et al [16] observed increase in HR by 5 bpm in 
control group and decrease in HR by 5 bpm in 
Dexmedetomidine group. 
In the control group, significant increase in HR 
occurred at various intervals after intubation at 1, 3, 5 
and 10 minutes with maximum rise of 36.24 bpm (1 
min after intubation). Similar findings were also noted 
by Aho et al [7] and Basar et al.[16]  
In Dexmedetomidine group there was a decrease in HR 
at 1 min after intubation and was sustained till 10th 
minute after intubation which was statistically highly 
significant (p=0.000). 
II. Changes in systolic blood pressure (SBP) 
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After Dexmedetomidine administration-After 
administration of Dexmedetomidine at 2nd minute 
there was a marginal and  insignificant increase of 
SBP. Similar observation was made by Aho et al.[7]  
From the 5th minute onwards, there was a gradual 
reduction in blood which was statistically highly 
significant. Aho et al [7] and Keniya pressure till 
induction et al[20] found a continuous gradual 
reduction of SBP as in our study. 
After induction-After induction there was a reduction 
of 7 mmHg of SBP in control group compared to 24 
mmHg in Dexmedetomidine group to basal value 
which is statistically significant. Similar observations 
were made by Kunisawa et al.[17]  
 
 
 
After laryngoscopy and intubation 
 
Table 5: Showing mean changes in SBP following laryngoscopy and intubation in Control and 
Dexmedetomidine group at various intervals 
 
S. 
No 
Author and year Mean change in SBP  in Control group Mean change in SBP in Study  
group 
  1 min 3 min 5 min 10 min 1 min 3 min 5 min 10 min 
1 Aho et al [7] 1991 +48 - - - +48 - - - 
2 Scheinin  et al [14] 
1992 
- - -18 - - - -22 - 
3 Jakola  et al [6] 1992 - - + - - - -17 - 
4 Kunisawa et al[17] 
2009 
+10 - - - -15 - - - 
5 Keniya et al[20] 2011 +30 - 10 - -10 - -20 - 
6 Present study +30.02 +21.02 +10.7 +0.78 -15.8 -22.3 -24.3 -26.0 
 
The sign (-) denotes decrease and (+) denotes increase 
in SBP. The spaces which have been left blank (‘ – ’), 
are the parameters not studied by the 
authors.Dexmedetomidine  blunts the increase in 
systolic blood pressure at 1, 3, 5 and 10 minutes 
following laryngoscopy and intubation compared to 
control group (p=0.000) which is statistically highly 
significant. Our findings are similar to those reported 
by Jakola et al, [6] Aho et al[7] and Scheinin et al. [14]  
III. Changes in diastolic blood pressure (DBP) 
After Dexmedetomidine administration-After 2nd 
minute there was a gradual decrease of DBP till 
induction which is statistically significant. In control 
group there was not much of variation in DBP till 
induction. 
Similar observations were also found by Aho et al,[7] 
Kunisawa et al [17] and Keniya et al.[20] where there 
was a decrease in DBP in Dexmedetomidine group and 
no change in control group. 
After induction-In the present study, there was a 
reduction of 6 mmHg in the control group and 18 
mmHg in Dexmedetomidine group compared to basal 
value which compares well with the findings of Jakola 
et al.[6]  
After laryngoscopy and intubation-In our study, 
there is an increase of DBP in control group which 
gradually decreased to near basal values by 10th 
minute. In Dexmedetomidine group, there is a decrease 
in DBP by 10th minute compared to basal values which 
is statistically highly significant. These findings are 
similar to findings of Jakola et al. [6]  
IV. Changes in mean arterial pressure (MAP) 
After Dexmedetomidine administration-From 5th 
minute onwards there is a continuous fall in MAP in 
Dexmedetomidine group till induction which is 
statistically significant. In control group not much of 
variation was observed regarding MAP till induction 
compared to basal values and to Dexmedetomidine 
group. Basar et al[16] also reported similar findings. 
After induction-After induction, the reduction in MAP 
in Dexmedetomidine group was higher than in control 
group which is similar to findings of Mowafi et al.[15]  
After laryngoscopy and intubation-Even at 10th 
minute the MAP was lower by 10 mmHg, compared to 
the basal values in Dexmedetomidine group while in 
the control group there was an increase in MAP which 
did not reach to basal values even after 10th minute. 
These findings concur with those of Mowafi et al [15] 
and Basar et al.[16]. 
Dose of thiopentone required for induction-In 
control group the mean dose of thiopentone for 
induction was 278 mg (4.96 mg/kg body weight) and in 
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Dexmedetomidine group it was 170.5 mg (3.08 mg/kg 
body weight) showing reduction of 1.88 mg/ kg body 
weight (38.66%) which is statistically highly 
significant (p=0.000). 
Jakola et al[6]and Aanta et al [21] also observed 23 
%and 37 % reduction in thiopentone dose requirements 
respectively in Dexmedetomidine group. 
Sedation scoring-In group C mean sedation score 
immediately after extubation was 2.62 and 2.52 in 
Dexmedetomidine group which was statistically not 
significant (p=0.087). 
There was no difference in both groups with respect to 
sedation and recovery which was similar to observation 
of Aanta et al [21]  
Side effects-In Dexmedetomidine group, 4 patients 
developed bradycardia and 3 patients had significant 
hypotension which was managed by injection atropine 
and intravenous fluids. 
 
Conclusion 
 
Laryngoscopy and endotracheal intubation are 
considered as the most critical events during 
administration of general anesthesia as they provoke 
transient but marked sympathoadrenal response which 
may result in intra-operative complications. 
Dexmedetomidine at a dose of 0.6µ/kg body weight 
given 10 minutes before induction significantly 
attenuated the hemodynamic responses to laryngoscopy 
and tracheal intubation. It also helps in reduction in 
dose requirement of thiopentone sodium. Side effects 
of Dexmedetomidine are minimal and can be managed 
easily. 
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